Weiqing Lu
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- CAR-T cell therapy research
Papers in
-
- RNA modifications and cancer 3
- RNA Research and Splicing 3
- Cancer-related gene regulation 2
- Melanoma and MAPK Pathways 1
-
- MicroRNA in disease regulation 2
- Co-authors
- Zhaoyong Liu (6 shared papers)Yang Xia (2 shared papers)Yelong Chen (2 shared papers)Suxia Lin (1 shared paper)Ying Zhang (1 shared paper)Jing‐Ping Yun (1 shared paper)Hu Wang (1 shared paper)Zhixiong Lin (1 shared paper)
- Journals
- Biomarker Research (1 paper)Molecular Oncology (1 paper)Biology Direct (1 paper)Cancer Letters (1 paper)RNA Biology (1 paper)
- Partner nations
- China
In The Last Decade
Weiqing Lu
8 papers receiving 275 citations
Peers
Comparison fields: 5 of 43
- Cancer Research 104
- Oncology 96
- Molecular Biology 185
- Immunology 48
- Pulmonary and Respiratory Medicine 38
Countries citing papers authored by Weiqing Lu
This map shows the geographic impact of Weiqing Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiqing Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiqing Lu more than expected).
Fields of papers citing papers by Weiqing Lu
This network shows the impact of papers produced by Weiqing Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiqing Lu. The network helps show where Weiqing Lu may publish in the future.
Co-authors
The 22 scholars most cited alongside Weiqing Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 117 | |
| 2 | 2022 | 67 | |
| 3 | 2020 | 51 | |
| 4 | 2021 | 27 | |
| 5 | 2023 | 9 | |
| 6 | 2024 | 3 | |
| 7 | 2025 | 2 | |
| 8 | 2024 | 2 |
About Weiqing Lu
Weiqing Lu is a scholar working on Molecular Biology, Cancer Research, Surgery, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 8 papers that have together received 278 indexed citations. Recurring topics across this work include RNA modifications and cancer (3 papers), RNA Research and Splicing (3 papers), MicroRNA in disease regulation (2 papers), Cancer-related gene regulation (2 papers), IL-33, ST2, and ILC Pathways (1 paper), Genetic factors in colorectal cancer (1 paper), Melanoma and MAPK Pathways (1 paper) and Lung Cancer Treatments and Mutations (1 paper). The work is most often cited by research in Cancer Research (104 citations), Oncology (96 citations), Molecular Biology (185 citations), Immunology (48 citations) and Pulmonary and Respiratory Medicine (38 citations). Weiqing Lu has collaborated with scholars based in China. Frequent co-authors include Zhaoyong Liu, Yang Xia, Yelong Chen, Suxia Lin, Ying Zhang, Jing‐Ping Yun, Hu Wang, Zhixiong Lin, Ying Zhang and Chuangzhen Chen. Their work appears in journals such as Biomarker Research, Molecular Oncology, Biology Direct, Cancer Letters and RNA Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.